Sunday , November 19 2017
Home / Tag Archives: incyte

Tag Archives: incyte

October, 2017

June, 2017

April, 2017

March, 2017

  • 31 March

    Incyte, Merck Provide Details on Collaboration of Epacadostat and Keytruda

    WILMINGTON, Del. & KENILWORTH, N.J.–(BUSINESS WIRE)–Incyte Corporation (Nasdaq:INCY) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced additional details of their clinical development program investigating the combination of epacadostat, Incyte’s investigational oral selective IDO1 enzyme inhibitor, with KEYTRUDA®(pembrolizumab), Merck’s anti-PD-1 therapy, in patients across five …

February, 2017

January, 2017

December, 2016

  • 22 December

    Incyte and Merus Partner to Discover and Develop Bispecific Antibodies

    WILMINGTON, Del. & UTRECHT, Netherlands–(BUSINESS WIRE)–Dec. 21, 2016– Incyte Corporation (NASDAQ:INCY) and Merus N.V. (NASDAQ:MRUS) announced today that they have entered into a global, strategic collaboration agreement focused on the research, discovery and development of bispecific antibodies utilizing Merus’ proprietary Biclonics® technology platform. The Collaboration and License Agreement grants Incyte …

October, 2016